The comprehensive results underscore the pivotal significance of m6A methylation and its associated regulatory elements, including METTL3, METTL14, FTO, and ALKBH5, in deciphering the initiation of AKI and in devising innovative therapeutic strategies. The gene discussed is METTL3; the disease is acute kidney injury.